Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Mellanox Adapters Selected By JD Cloud To Boost Efficiency

Published 03/05/2019, 07:59 AM
Updated 07/09/2023, 06:31 AM

Mellanox Technologies, Ltd. (NASDAQ:MLNX) has been securing notable customer wins on the back of its strength in Ethernet-based portfolio. Recently, the company announced that JD.com (NASDAQ:JD) , a Chinese e-commerce company, is leveraging its ConnectX Ethernet network adapters.

The move enables JD cloud to develop applications, network function virtualization, and enhance the efficiency of Software-Defined Networking (“SDN”) by leveraging ConnectX adapters with Accelerated Switching and Packet Processing (“ASAP2”) technology.

The adapters have a data transfer speed of 25 to 100 Gbps (or Gigabits per second) which in turn bolsters cloud deployments. Mellanox’s Ethernet adapters offer low latency and high throughput levels required to accelerate various applications of production network of JD cloud data center. Management remains elated with the deployment of its advanced ASAP2 technology which is aiding JD.com in supporting dynamic workloads in a cost-effective manner.

Advanced storage media performance on various fabrics, cost-efficiency, scalability of node capacities and support through automation, are notable features which favor the deployment of Mellanox’s ConnectX network adapters among cloud storage customers.

Shares of Mellanox have gained 58.2% in the last year, substantially outperforming the industry’s rally of 7.4%.

What Investors’ Need to Know

Notably, per recent IDC estimates, the global datasphere will grow to 175 zettabytes (that is a trillion gigabytes) by 2025, from 33 zettabytes in 2018. This exponential growth is anticipated to favor adoption of Mellanox’s interconnect solutions driven by growing demand for higher network speeds for fast processing of data.

The company is one of the major suppliers of 25, 50, and 100GB Ethernet adapters, switches, and cables to the market today. In fact, per Crehan research estimates, Mellanox had a market share of 69% in the high-speed Ethernet adapter business in second-quarter 2018, leaving Intel (NASDAQ:INTC) , Broadcom (NASDAQ:AVGO) , Cisco (NASDAQ:CSCO) and other peers trailing.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In fact, the company’s Ethernet adapters have been also deployed in production network of Alibaba's (NYSE:BABA) Infrastructure Services.

In the fourth quarter of 2018, the company’s Ethernet business grew 21% year over year on account of robust adoption of the company’s high-speed Ethernet network adapters and LinkX transceivers and cables.

The need to access and process data at a faster speed due to data growth is fueling increased demand for high-speed Ethernet adapters.

To Conclude

Mellanox is benefiting from solid demand of its Gigabit EDR solutions in machine learning, artificial intelligence, high-performance computing, database and storage.

Further, robust demand for Mellanox’s InfiniBand solutions is a key catalyst. The company has also won several contracts from the likes of NetApp (NASDAQ:NTAP), the University of Toronto and NASA Ames Research Center, which further reflects sturdy demand for its solutions.

We believe the company’s enhancements in its product portfolio with robust capabilities; inorganic additions and expanding customer base favor company’s growth prospects.

Zacks Rank

Mellanox currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See these 7 breakthrough stocks now>>



JD.com, Inc. (JD): Free Stock Analysis Report

Mellanox Technologies, Ltd. (MLNX): Free Stock Analysis Report

Broadcom Inc. (AVGO): Free Stock Analysis Report

Intel Corporation (INTC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.